专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

US06692722B2 Manufacturing method of zeolite from waste 失效
标题翻译：从废物中制备沸石的方法
公开(公告)号：US06692722B2
公开(公告)日：2004-02-17
申请号：US10184067
申请日：2002-06-28
申请人： Takao Ando , Teruo Henmi , Yoshihisa Asada
发明人： Takao Ando , Teruo Henmi , Yoshihisa Asada
IPC分类号： C01B3902
CPC分类号： C01B39/02
摘要： The present invention provides a zero emission type method for effective use permitting economical and effective manufacture of zeolite effectively applicable in various sectors of industry by using silicon-containing waste comprising at least one of exhaust gas treatment sludge mainly comprising SiO2 discharged from an optical film manufacturing plant, optical fiber refuse and preform refuse, and aluminum-containing waste comprising at least one of aluminum dross discharged from an aluminum-related manufacturing plant, aluminum dust collection ashes, sludge mainly comprising aluminum hydroxide, cleaning waste liquid of aluminum or an alloy thereof, scrap of metal aluminum or an alloy thereof, and alumina scrap.
摘要翻译：本发明提供了一种有效利用的零排放型方法，其允许经济有效地制造有效地适用于工业各个部门的沸石，该方法是使用含有废弃物的废弃物，其中废气处理污泥主要包括从光学膜制造中排出的SiO 2 装置，光纤垃圾和预制件垃圾，以及含铝废物，其包含从铝相关制造厂排出的铝渣中的至少一种，铝灰尘收集灰，主要包含氢氧化铝的污泥，铝的清洗废液或其合金，金属铝或其合金的废料和氧化铝废料。

2. 发明授权

US5578680A Vibration-absorbing elastomeric composite, process for making the same, and vibration damper comprising the same 失效
标题翻译：振动吸收弹性体复合材料，其制造方法以及包括该复合材料的振动阻尼器
公开(公告)号：US5578680A
公开(公告)日：1996-11-26
申请号：US121880
申请日：1993-09-17
申请人： Takao Ando , Katsura Gohda , Eiji Ichihara , Hiroshi Itayama
发明人： Takao Ando , Katsura Gohda , Eiji Ichihara , Hiroshi Itayama
IPC分类号： C08G18/08 , C08L23/02 , C08L23/08 , C08L23/14 , C08L23/16 , C08L23/18 , C08L23/22 , C08L23/26 , C08L71/02 , C08L75/00 , C08L75/04 , C08L87/00 , F16F7/00 , F16F15/08
CPC分类号： C08L23/22 , C08G18/0838 , C08L23/02 , C08L23/08 , C08L23/16 , C08L75/04 , C08G2350/00 , C08L2205/03 , C08L23/14 , C08L51/06 , C08L71/02
摘要： Vibration-absorbing elastomeric composites, having improved vibration-damping properties with improved moldability and resin properties suitable for molded products, are obtained by reacting, insitu in a melted thermoplastic resin such as olefin-diene copolymer, a polyisocyanate with a polyol to form a polyurethane having a nitrogen atom content of at least 3% and having a solubility parameter which is higher by at least 2.5 than that of said thermoplastic resin.
摘要翻译：通过使熔融的热塑性树脂如烯烃 - 二烯共聚物，多异氰酸酯与多元醇反应形成聚氨酯，从而获得具有改善的成型性和适于成型产品的树脂性能的减振弹性体复合材料。具有至少3％的氮原子含量并且具有比所述热塑性树脂的溶解度参数高至少2.5的溶解度参数。

3. 发明授权

US5508298A Azole derivative and pharmaceutical composition 失效
标题翻译：唑衍生物和药物组合物
公开(公告)号：US5508298A
公开(公告)日：1996-04-16
申请号：US444027
申请日：1995-05-18
申请人： Koichi Niimura , Takao Ando , Toyohiko Nitta , Yuko Ikeda
发明人： Koichi Niimura , Takao Ando , Toyohiko Nitta , Yuko Ikeda
IPC分类号： C07C45/62 , C07C45/68 , C07C49/657 , C07C49/683 , C07C49/697 , C07C49/747 , C07C255/56 , C07D233/60 , C07D249/08 , C07D303/04 , C07D303/08 , C07D303/14 , C07D303/46 , C07D521/00 , A61K31/41
CPC分类号： C07D231/12 , C07C255/56 , C07C45/62 , C07C45/68 , C07C49/657 , C07C49/683 , C07C49/697 , C07C49/747 , C07D233/56 , C07D249/08 , C07D303/04 , C07D303/08 , C07D303/14 , C07D303/46 , C07C2101/14 , C07C2101/16
摘要： A novel azole derivative of the general formula (I): ##STR1## wherein R.sub.1 and R.sub.2 are, independently from each other, a hydrogen atom or an alkyl group having 1 to 4 carbon atoms, x.sub.1 and x.sub.2 are, independently from each other, a hydrogen or halogen atom, or hydroxyl, cyano, or trifluoromethyl group, and Y is CH or a nitrogen atom, a process for the production thereof, and a pharmaceutical composition containing the same as the active ingredient.
摘要翻译：通式（I）的新型唑衍生物：其中R 1和R 2彼此独立地为氢原子或具有1至4个碳原子的烷基，其中x 1和x 2独立地为氢或卤素原子，或羟基，氰基或三氟甲基，Y为CH或氮原子，其制备方法和含有该活性成分的药物组合物。

4. 发明授权

US5489597A Azole derivative and pharmaceutical composition 失效
标题翻译：唑衍生物和药物组合物
公开(公告)号：US5489597A
公开(公告)日：1996-02-06
申请号：US137045
申请日：1993-10-14
申请人： Koichi Niimura , Takao Ando , Toyohiko Nitta , Yuko Ikeda
发明人： Koichi Niimura , Takao Ando , Toyohiko Nitta , Yuko Ikeda
IPC分类号： C07C45/62 , C07C45/68 , C07C49/657 , C07C49/683 , C07C49/697 , C07C49/747 , C07C255/56 , C07D233/60 , C07D249/08 , C07D303/04 , C07D303/08 , C07D303/14 , C07D303/46 , C07D521/00 , A61K31/415
CPC分类号： C07D231/12 , C07C255/56 , C07C45/62 , C07C45/68 , C07C49/657 , C07C49/683 , C07C49/697 , C07C49/747 , C07D233/56 , C07D249/08 , C07D303/04 , C07D303/08 , C07D303/14 , C07D303/46 , C07C2101/14 , C07C2101/16
摘要： A novel azole derivative of the general formula (I): ##STR1## wherein R.sub.1 and R.sub.2 are, independently from each other, a hydrogen atom or an alkyl group having 1 to 4 carbon atoms, X.sub.1 and X.sub.2 are, independently from each other, a hydrogen or halogen atom, or hydroxyl, cyano, or trifluoromethyl group, and Y is CH or a nitrogen atom, a process for the production thereof, and a pharmaceutical composition containing the same as the active ingredient.
摘要翻译： PCT No.PCT / JP93 / 00181 Sec。 371日期：1993年10月14日 102（e）日期1993年10月14日PCT提交1993年2月12日PCT公布。公开号WO93 / 16052 日本8月19日，1993.通式（I）的新型唑衍生物：其中R 1和R 2彼此独立地为氢原子或具有1至4个碳原子的烷基， X 1和X 2彼此独立地为氢或卤素原子，或羟基，氰基或三氟甲基，Y为CH或氮原子，其制备方法和含有其的药物组合物有效成分。

5. 发明授权

US5462957A Azole derivatives, pharmaceutical compositions containing the same, and method for treating mycosis and estrogen-dependent diseases 失效
公开(公告)号：US5462957A
公开(公告)日：1995-10-31
申请号：US365128
申请日：1994-12-28
申请人： Koichi Niimura , Yuko Ikeda , Akira Kato , Takao Ando
发明人： Koichi Niimura , Yuko Ikeda , Akira Kato , Takao Ando
IPC分类号： A61K31/41 , A61K31/415 , A61P31/04 , A61P31/10 , A61P35/00 , A61P43/00 , C07D249/08 , C07D307/33 , C07D333/38 , C07D403/06 , C07D405/06 , C07D409/06 , C07D493/10 , C07D495/10 , C07D521/00
CPC分类号： C07D249/08 , C07D231/12 , C07D233/56
摘要： Azole derivatives (including stereoisomers and pharmaceutically acceptable salts) of the formula: ##STR1## wherein R.sub.1 and R.sub.2 each are H or C.sub.1 -C.sub.4 alkyl; R.sub.3 is H, OH, CN, halogen, haloalkyl, C.sub.1 -C.sub.4 alkyl or phenyl, and if there are two or more R.sub.3 groups, such R.sub.3 groups may be the same or different; n is an integer from 0 to 5; Y is N or CH; and X is O, S or NH have antimycotic and aromatase inhibitory activities. Compositions containing the azole derivatives and a method of treating mycosis and estrogen-dependent diseases by administering effective quantities of the azole derivatives are also disclosed.

6. 发明授权

US5432190A Pharmaceutical compositions containing triazoles and method of treating estrogen-dependent diseases 失效
标题翻译：含有三唑的药物组合物和治疗雌激素依赖性疾病的方法
公开(公告)号：US5432190A
公开(公告)日：1995-07-11
申请号：US183339
申请日：1994-01-19
申请人： Koichi Niimura , Yuko Ikeda , Akira Kato , Takao Ando
发明人： Koichi Niimura , Yuko Ikeda , Akira Kato , Takao Ando
IPC分类号： A61K31/41 , A61K31/415 , A61P31/04 , A61P31/10 , A61P35/00 , A61P43/00 , C07D249/08 , C07D307/33 , C07D333/38 , C07D403/06 , C07D405/06 , C07D409/06 , C07D493/10 , C07D495/10 , C07D521/00 , A61K31/34 , A61K31/38 , A61K31/40
CPC分类号： C07D249/08 , C07D231/12 , C07D233/56
摘要： Azole derivatives (including stereoisomers and pharmaceutically acceptable salts) of the formula: ##STR1## wherein R.sub.1 and R.sub.2 each are H or C.sub.1 -C.sub.4 alkyl; R.sub.3 is H, OH, CN, halogen, haloalkyl, C.sub.1 -C.sub.4 alkyl or phenyl, and if there are two or more R.sub.3 groups, such R.sub.3 groups may be the same or different; n is an integer from 0 to 5; Y is N or CH; and X is O, S or NH have antimycotic and aromatase inhibitory activities. Compositions containing the azole derivatives and a method of treating mycosis and estrogen-dependent diseases by administering effective quantities of the azole derivatives are also disclosed.
摘要翻译：式：-C 1-4烷基的唑衍生物（包括立体异构体和药学上可接受的盐） R3是H，OH，CN，卤素，卤代烷基，C1-C4烷基或苯基，如果有两个或更多个R 3基团，则这样的R 3基团可以相同或不同; n为0〜5的整数， Y为N或CH; X是O，S或NH具有抗真菌和芳香酶抑制活性。还公开了含有唑衍生物的组合物和通过施用有效量的唑衍生物治疗真菌病和雌激素依赖性疾病的方法。

7. 发明授权

US4874750A Pharmaceutical composition containing a derivative of para-aminobenzoic acid as an active ingredient 失效
标题翻译：含有对氨基苯甲酸衍生物作为活性成分的药物组合物
公开(公告)号：US4874750A
公开(公告)日：1989-10-17
申请号：US908273
申请日：1986-09-17
申请人： Chikao Yoshikumi , Yoshio Ohmura , Fumio Hirose , Masanori Ikuzawa , Kenichi Matsunaga , Takayoshi Fujii , Minoru Ohhara , Takao Ando
发明人： Chikao Yoshikumi , Yoshio Ohmura , Fumio Hirose , Masanori Ikuzawa , Kenichi Matsunaga , Takayoshi Fujii , Minoru Ohhara , Takao Ando
IPC分类号： C07H15/203
CPC分类号： C07H15/203
摘要： Disclosed is a pharmaceutical composition containing an aminobenzoic acid derivative as an active ingredient represented by the following general formula: ##STR1## wherein .sup.1 R donotes one member selected from the group consisting of the residual groups formed by removing OH at 1(alpha) or 1(beta) position from arabinose, glucose, galactose and mannose, or a pharmaceutically acceptable salt thereof.
摘要翻译：本发明公开了含有氨基苯甲酸衍生物作为活性成分的药物组合物，其由以下通式表示：其中，R 1表示选自由1（α）或1（α）除去OH而形成的残基， β）位置，或其药学上可接受的盐。

8. 发明授权

US4748159A Method for the treatment of tumors 失效
标题翻译：肿瘤治疗方法
公开(公告)号：US4748159A
公开(公告)日：1988-05-31
申请号：US931974
申请日：1986-11-24
申请人： Chikao Yoshikumi , Yoshio Ohmura , Fumio Hirose , Masanori Ikuzawa , Kenichi Matsunaga , Takayoshi Fujii , Minoru Ohhara , Takao Ando
发明人： Chikao Yoshikumi , Yoshio Ohmura , Fumio Hirose , Masanori Ikuzawa , Kenichi Matsunaga , Takayoshi Fujii , Minoru Ohhara , Takao Ando
IPC分类号： C07H15/203 , A61K31/70 , C07H1/00
CPC分类号： C07H15/203
摘要： Disclosed is a method for the treatment of hyperglycemia, hyperlipemia, inflammatory diseases, pains due to the accentuation of central nerve, pyrexia due to the accentuation of central nerve or tumor, which comprises administering to a patient suffering therefrom a pharmaceutically effective amount of p-aminobenzoic acid-N-L-rhamnoside or a pharmaceutically acceptable salt thereof.
摘要翻译：本发明公开了一种治疗高血糖症，高脂血症，炎症性疾病，由于中枢神经突出而引起的疼痛，由于中枢神经或肿瘤引起的发热，其包括向患有其的药物有效量的对 - 氨基苯甲酸-NL-鼠李糖苷或其药学上可接受的盐。

9. 发明授权

US4708950A Pharmaceutical composition containing a derivative of orthoaminobenzoic acid as an active ingredient 失效
标题翻译：含有邻氨基苯甲酸衍生物作为活性成分的药物组合物
公开(公告)号：US4708950A
公开(公告)日：1987-11-24
申请号：US574533
申请日：1984-01-27
申请人： Chikao Yoshikumi , Yoshio Ohmura , Fumio Hirose , Masanori Ikuzawa , Kenichi Matsunaga , Takayoshi Fujii , Minoru Ohhara , Takao Ando
发明人： Chikao Yoshikumi , Yoshio Ohmura , Fumio Hirose , Masanori Ikuzawa , Kenichi Matsunaga , Takayoshi Fujii , Minoru Ohhara , Takao Ando
IPC分类号： A61K31/70 , A61K31/7028 , A61K31/7034 , A61P35/00 , C07H15/203
CPC分类号： C07H15/203
摘要： Disclosed is a pharmaceutical composition containing an aminobenzoic acid derivative as an active ingredient represented by the following general formula: ##STR1## wherein .sup.1 R denotes one member selected from the group consisting of the residual groups formed by removing OH at 1(alpha) or 1(beta) position from arabinose, xylose, glucose, galactose, rhamnose and mannose, and .sup.2 R denotes hydrogen or methyl group, or a pharmaceutically acceptable salt thereof.
摘要翻译：本发明公开了一种含有氨基苯甲酸衍生物作为活性成分的药物组合物，由以下通式表示：其中1R表示选自由1（α）或1（α）除去OH而形成的残基， β-葡萄糖，半乳糖，鼠李糖和甘露糖，2R表示氢或甲基，或其药学上可接受的盐。

10. 发明授权

US4681877A Pivaloyloxymethyl 7-.beta.-[2-(2-amino-4-thiazolyl)-2-methoxyiminoacetamido]-3-(2-amino-1, 3-thiadiazolyl-5-thiomethyl)-3-cepheme-4-carboxylate and pharmaceutical composition containing the same 失效
标题翻译： 3- [2-（2-氨基-4-噻唑基）-2-甲氧基亚氨基乙酰氨基] -3-（2-氨基-1,3-噻二唑基-5-硫代甲基）-3-头孢烯-4-羧酸酯的新戊酰氧基甲酯和药物含有相同的组合物
公开(公告)号：US4681877A
公开(公告)日：1987-07-21
申请号：US562003
申请日：1983-12-16
申请人： Shigeaki Muto , Takao Ando , Takayoshi Fujii , Akihiko Kanno , Yoko Onishi , Isamu Motokawa , Takao Furusho , Chikao Yoshikumi
发明人： Shigeaki Muto , Takao Ando , Takayoshi Fujii , Akihiko Kanno , Yoko Onishi , Isamu Motokawa , Takao Furusho , Chikao Yoshikumi
IPC分类号： A61K31/545 , C07D501/36 , C07D501/56
CPC分类号： C07D501/36
摘要： Disclosed herein are 7-beta-[2-(2-amino-4-thiazolyl)-2-methoxyiminoacetamido]-3-(2-amino-1,3,4-thiadiazolyl-5-thiomethyl)-3-cepheme-4-carboxylic acid, salts thereof and pivaloyloxymethyl ester thereof, and a pharmaceutical composition containing the same as an active ingredient.
摘要翻译：本文公开了7-β-（2-（2-氨基-4-噻唑基）-2-甲氧基亚氨基乙酰氨基] -3-（2-氨基-1,3,4-噻二唑基-5-硫代甲基）-3-头孢烯-4 - 羧酸，其盐和新戊酰氧基甲酯，以及含有它们作为活性成分的药物组合物。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式